Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Clinical and Magnetic Resonance Imaging (MRI) Distinctions Between Tumefactive Demyelination and Brain Tumors in Children.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
Facial hypersensitivity and trigeminal pathology in mice with experimental autoimmune encephalomyelitis (EAE).
Protective Autoimmunity: A Unifying Model for the Immune Network Involved in CNS Repair.
Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature.
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis.
Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Neurological perspectives on voltage-gated sodium channels.
Multiple sclerosis in New Zealand Māori.
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
Multiple sclerosis update.
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
IL-17F but not IL-17A gene polymorphism confers risk to multiple sclerosis in a Chinese Han population.
Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients.
Core muscle strength and endurance measures in ambulatory persons with multiple sclerosis: validity and reliability.
Managing psychological stress in the multiple sclerosis medical visit: Patient perspectives and unmet needs.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.
Urinary tract infections in multiple sclerosis.
Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop.
Menopause in multiple sclerosis: therapeutic considerations.

Pages